论文部分内容阅读
目的分析探究静脉溶栓治疗对于急性脑梗死患者的临床有效性及安全性。方法回顾性分析2007年1月至2009年12月期间在我院神经内科住院经静脉溶栓治疗的32例急性脑梗死患者的临床资料。32例患者为发病时间<3h的急性脑梗死患者,医生根据患者经济条件选用UK进行静脉内溶栓治疗,并观察患者安全性。结果所有患者中,经溶栓治疗后3h内症状完全消失者12例,占37.5%;溶栓治疗后症状好转及症状未有发展者18例,占56.25%;治疗后症状继续加重者2例,占6.25%。结论静脉溶栓疗法对于急性脑梗死患者,应用越早,安全疗效越好。
Objective To investigate the clinical efficacy and safety of intravenous thrombolytic therapy in patients with acute cerebral infarction. Methods The clinical data of 32 patients with acute cerebral infarction treated with intravenous thrombolysis in our hospital from January 2007 to December 2009 were analyzed retrospectively. Thirty-two patients were acute cerebral infarction patients with onset time less than 3 hours. Doctors chose UK for intravenous thrombolysis according to the economic conditions of patients and observed the safety of the patients. Results In all the patients, 12 cases (37.5%) disappeared within 3 hours after thrombolytic therapy, 18 cases (56.25%) improved symptoms after thrombolysis and no symptoms developed, and 2 cases continued to worsen after treatment , Accounting for 6.25%. Conclusion Intravenous thrombolytic therapy for patients with acute cerebral infarction, the application of the earlier, the better the safety effect.